£40.90

GRIN Verlag Prolonged antibiotic therapy in PCR confirmed persistent Lyme disease

Price data updated today

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£41 today · previous high £41 · all-time low £2

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 91 days • 91 data points

Historical
Generating forecast...
£40.90 £0.00 £8.95 £17.90 £26.86 £35.81 £44.76 17 March 2026 08 April 2026 01 May 2026 23 May 2026 15 June 2026

Price Distribution

Price distribution over 91 days • 2 price levels

Days at Price
Current Price
87 days 4 days · current 0 22 44 65 87 £2.28 £41 Days at Price

Price Analysis

Most common price: £2.28 (87 days, 95.6%)

Price range: £2.28 - £41

Price levels: 2 different prices over 91 days

Description

Scientific Study from the year 2011 in the subject Medicine - Internal Medicine, , language: English, abstract: We examined a sample of 90 individuals that had previously received a course of appropriate antibiotics for Lyme disease without experiencing full resolution of their symptoms and had evidence of persistent infection documented by PCR analysis. Mean duration of symptoms was 9.5 years (range 1 - 40 years). The treatment was adapted to the individual case according to clinical response. Long term antibiotic therapy was initiated and patients were treated continuously for at least 6 months, in some cases several years of intermittent therapy was administered. About 38,8% of the patients experienced full remission of symptoms while about 56,7% reported a significant improvement, 5,6% of patients were deemed refractory to therapy. Therapeutic modalities are discussed in detail.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
20 February 2011
Listed Since
23 February 2011

Barcode

No barcode data available